This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Apr;21(4):854-8.

doi: 10.1093/ndt/gfk086. Epub 2006 Jan 31.

Is it time for spironolactone therapy in dialysis patients?

Adrian Covic, Paul Gusbeth-Tatomir, David J A Goldsmith

PMID: 16449287
DOI: 10.1093/ndt/gfk086

Editorial

Is it time for spironolactone therapy in dialysis patients?

Adrian Covic et al. Nephrol Dial Transplant. 2006 Apr.

. 2006 Apr;21(4):854-8.

doi: 10.1093/ndt/gfk086. Epub 2006 Jan 31.

Authors

Adrian Covic, Paul Gusbeth-Tatomir, David J A Goldsmith

PMID: 16449287
DOI: 10.1093/ndt/gfk086

No abstract available

PubMed Disclaimer

Comment in

MR blockade in patients with chronic renal disease--not the more the merrier, but the earlier the better.
Lepenies J, Quinkler M. Lepenies J, et al. Nephrol Dial Transplant. 2006 Nov;21(11):3343-4. doi: 10.1093/ndt/gfl371. Epub 2006 Jul 5. Nephrol Dial Transplant. 2006. PMID: 16822786 No abstract available.

Similar articles

Primary hyperaldosteronism in a patient with end-stage renal disease.
Kazory A, Weiner ID. Kazory A, et al. Nephrol Dial Transplant. 2007 Mar;22(3):917-9. doi: 10.1093/ndt/gfl702. Epub 2006 Nov 24. Nephrol Dial Transplant. 2007. PMID: 17127694 No abstract available.
Spironolactone and ACE inhibition in chronic renal failure.
Almirall J, Lopez T. Almirall J, et al. N Engl J Med. 2002 Feb 7;346(6):456-7. N Engl J Med. 2002. PMID: 11837270 No abstract available.
MR blockade in patients with chronic renal disease--not the more the merrier, but the earlier the better.
Lepenies J, Quinkler M. Lepenies J, et al. Nephrol Dial Transplant. 2006 Nov;21(11):3343-4. doi: 10.1093/ndt/gfl371. Epub 2006 Jul 5. Nephrol Dial Transplant. 2006. PMID: 16822786 No abstract available.
Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
Bansal S, Lindenfeld J, Schrier RW. Bansal S, et al. Circ Heart Fail. 2009 Jul;2(4):370-6. doi: 10.1161/CIRCHEARTFAILURE.108.821199. Circ Heart Fail. 2009. PMID: 19808361 Review.
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
Gaddam KK, Pratt-Ubunama MN, Calhoun DA. Gaddam KK, et al. Expert Rev Cardiovasc Ther. 2006 May;4(3):353-9. doi: 10.1586/14779072.4.3.353. Expert Rev Cardiovasc Ther. 2006. PMID: 16716096 Review.

See all similar articles

Cited by

[Modern pharmacological aspects of hyperaldosteronism therapy].
Quinkler M, Reincke M. Quinkler M, et al. Internist (Berl). 2006 Sep;47(9):953-9. doi: 10.1007/s00108-006-1681-0. Internist (Berl). 2006. PMID: 16823578 Review. German.
Reducing cardiovascular mortality in chronic kidney disease: something borrowed, something new.
Quarles LD. Quarles LD. J Clin Invest. 2013 Feb;123(2):542-3. doi: 10.1172/JCI67203. Epub 2013 Jan 9. J Clin Invest. 2013. PMID: 23298840 Free PMC article. Review.
A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients.
Vukusich A, Kunstmann S, Varela C, Gainza D, Bravo S, Sepulveda D, Cavada G, Michea L, Marusic ET. Vukusich A, et al. Clin J Am Soc Nephrol. 2010 Aug;5(8):1380-7. doi: 10.2215/CJN.09421209. Epub 2010 Jun 3. Clin J Am Soc Nephrol. 2010. PMID: 20522535 Free PMC article. Clinical Trial.
Long-term effects of spironolactone in peritoneal dialysis patients.
Ito Y, Mizuno M, Suzuki Y, Tamai H, Hiramatsu T, Ohashi H, Ito I, Kasuga H, Horie M, Maruyama S, Yuzawa Y, Matsubara T, Matsuo S; Nagoya Spiro Study Group. Ito Y, et al. J Am Soc Nephrol. 2014 May;25(5):1094-102. doi: 10.1681/ASN.2013030273. Epub 2013 Dec 12. J Am Soc Nephrol. 2014. PMID: 24335969 Free PMC article. Clinical Trial.
Aldosterone and mortality in hemodialysis patients: role of volume overload.
Hung SC, Lin YP, Huang HL, Pu HF, Tarng DC. Hung SC, et al. PLoS One. 2013;8(2):e57511. doi: 10.1371/journal.pone.0057511. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23469009 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information